1.
Lancet Gastroenterol Hepatol
; 8(4): 297-299, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: covidwho-2277557
2.
Rev. Assoc. Med. Bras. (1992)
; 66(9):1169-1171, 2020.
Artículo
en Inglés
| LILACS (Américas) | ID: grc-742501
3.
Rev Assoc Med Bras (1992)
; 66(9): 1169-1171, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: covidwho-836012
4.
Drug Discov Today
; 25(6): 956-958, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: covidwho-88528
RESUMEN
This article examines three aspects of antivirals, such as hydroxychloroquine, chloroquine, and remdesvir, as they might relate to the treatment of a viral infection such as COVID-19: (i) the use of vaporization for the delivery of antivirals, with the bulk constituents having mild antiviral efficacy; (ii) the application of a marine natural product extract as opposed to a single molecule as an antiviral agent; and (iii) a counter intuitive approach to formulation that is, in part, based on delivering multiple species that fall into three categories: building blocks for the virus to accelerate replication; an energy source for the infected cell to boost its immune response; and the species that antagonize or provide toxicity to the virus.